Back to 
Morgan Stanley
Morgan Stanley
OMIC
4 quarters
Position history for Morgan Stanley's holdings in SINGULAR GENOMICS SYSTEMS IN
No. Morgan Stanley exited its OMIC (Singular Genomics Systems in) position in Q1 2025. Its Q4 2024 13F listed 1,896 shares worth $36,839. Morgan Stanley already held OMIC in its Q2 2024 13F, the earliest on record, and held it in 3 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$3,068
Total Shares Change
-363
Quarter-by-Quarter History
Other major holders of OMIC: UBS Group AG, FMR LLC, Vanguard Group Inc.